Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free biolimus A9-coated stent: insights from the all-comers FREEDOM registry
Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study
Final 5-year outcomes of the TRIAS High Risk of Restenosis; a multi-centre, randomized trial comparing endothelial progenitor cell capturing stent with drug-eluting stents